Lineage Provides Update on COR1 Cell Therapy Program for Corneal Endothelial Disease

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. HUVR:IN
2. NKE
3. PANW
4. CL
5. SNDK
6. TAP
7. DELL
8. ROIV
9. ANET
10. BE

Go back to Lineage Provides Update on COR1 Cell Therapy Program for Corneal Endothelial Disease
(NYSE: LCTX) Delayed: 1.08 -0.02 (1.82%)
Previous Close $1.10    52 Week High $ 
Open $1.09    52 Week Low $ 
Day High $1.11    P/E N/A 
Day Low $1.08    EPS $ 
Volume 535,726       

(NYSE: LCTX) Delayed: 1.08 -0.02 (1.82%)
Previous Close $1.10    52 Week High $ 
Open $1.09    52 Week Low $ 
Day High $1.11    P/E N/A 
Day Low $1.08    EPS $ 
Volume 535,726